Amiselimod hydrochloride
Amiselimod hydrochloride
Catalog No. M16743
A novel prodrug S1P receptor modulator lacking S1P3 receptor agonism to avoid bradycardia associated with fingolimod and other S1P receptor modulators.
| Size | Price / USD | Stock | Quantity |
| 2MG | 49 | Get Quote |
|
| 5MG | 80 | Get Quote |
|
| 10MG | 120 | Get Quote |
|
| 25MG | 203 | Get Quote |
|
| 50MG | 357 | Get Quote |
|
| 100MG | 537 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAmiselimod hydrochloride
-
Brief Description
-
Description
-
Storage
-
NoteResearch use only, not for human use.
-
Reference1. Sugahara K, et al. Br J Pharmacol. 2017 Jan;174(1):15-27. 2. Kappos L, et al. Lancet Neurol. 2016 Oct;15(11):1148-59. 3. Harada T, et al. Br J Clin Pharmacol. 2017 May;83(5):1011-1027.
molnova catalog
related products
-
Ponesimod
A potent, selective, orally active S1P1 receptor agonist with EC50 of 9.1 nM; shows weak activity on S1P3 (EC50=123 nM).
-
ASP6432
ASP6432 (ASP-6432) is a potent and selective antagonist of LPA1 receptor, does-dependently inhibits LPA-stimulated increase in intracellular calcium ion with IC50 of 11 nM.
-
SAR-100842
SAR-100842 (SAR100842) is a potent, selective, orally available antagonist of the Lysophosphatidic Acid 1 Receptor (LPA1 receptor) with IC50 of 31 nM in β-arrestin assays.
Cart
sales@molnova.com